ZHANG Haiyu, LIU Wenke. Treating DPN Based on Collateral Diseases by Professor TONG Xiaolin[DB/OL].(2023-08-01)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.19664/j.cnki.1002-2392.220178
DOI:
ZHANG Haiyu, LIU Wenke. Treating DPN Based on Collateral Diseases by Professor TONG Xiaolin[DB/OL].(2023-08-01)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.19664/j.cnki.1002-2392.220178DOI:
Treating DPN Based on Collateral Diseases by Professor TONG Xiaolin
Diabetic peripheral neuropathy(DPN)is one of the most common chronic complications of diabetes mellitus(DM). Professor TONG Xiaolin classified DPN as ‘blood glucose collateral disease’ and thought it was in the ‘deficiency and damage’ stage of DM. It may originate from ‘Xiao Dan’or ‘Pi Dan’, which eventually leads to peripheral neuropathy due to collateral stasis. According to the degree of collateral disease, DPN is divided into early collateral stasis, midterm collateral stasis, late collateral closure and collateral damage, which guides syndrome differentiation by stages. The treatment of DPN should be adjusted as a whole, treat the collateral throughout the whole process, select the prescription based on syndrome differentiation and modify the prescription according to clinical symptoms.
SOBHANI S, ASAYESH H, SHARIFI F, et al. Prevalence of diabetic peripheral neuropathy in Iran: a systematic review and meta-analysis[J]. J Diabetes Metab Disord, 2014, 13(1):97-104.
TADESSE D B, GEBREWAHD G T, HAILAY A, et al. Diabetic peripheral neuropathy in ethiopia: a systematic review and meta-analysis[J]. J Diabetes Res, 2021, 2021:5304124.
SHIFERAW W S, AKALU T Y, WORK Y, et al. Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis[J]. BMC Endocr Disord, 2020, 20(1):49-58.
MORRISON S, COLBERG S R, PARSON H K, et al. Relation between risk of falling and postural sway complexity in diabetes[J]. Gait Posture, 2012, 35(4):662-668.
LECHLEITNER M, ABRAHAMIAN H, FRANCESCONI C, et al. Diabetic neuropathy and diabetic foot syndrome(update 2019)[J]. Wien Klin Wochenschr, 2019, 131(suppl 1):141-150.
CALLAGHAN B C, CHENG H T, STABLES C L, et al. Diabetic neuropathy: clinical manifestations and current treatments[J]. Lancet Neurol, 2012, 11(6):521-534.
BURSAC S N, JANDRIC S, TALIC G. Influence of diabetic distal symmetric polyneuropathy on the performance of the musculoskeletal system of lower leg and foot[J]. Med Arch, 2019, 73(4):262-267.
CALLAGHAN B C, LITTLE A A, FELDMAN E L, et al. Enhanced glucose control for preventing and treating diabetic neuropathy[J]. Cochrane Database Syst Rev, 2012, 6(6): CD007543.
SATOH J, YAGIHASHI S, BABA M, et al. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial[J]. Diabet Med, 2011, 28(1):109-116.
ZIEGLER D, LOW P A, LITCHY W J, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial[J]. Diabetes Care, 2011, 34(9):2054-2060.
A case study of the treatment of a hyperthyroidism patient allergic to methimazole by Academician Tong Xiaolin
Discussion on TCM treatment of Wagner Grade 0 diabetic foot based on qi and blood theory
A case report of the treatment of diabetic kidney disease at the stage of macroalbuminuria by Academician Tong Xiaolin
Syndrome Differentiation and Treatment of COVID-19 by Academician Tong Xiaolin:Origin, Innovation, and Development of "Cold-Dampness Plague" Theory
A case report about Professor Tong Xiaolin’s diagnosis and treatment of adult type 1 brittle diabetes with multiple system complications by the state-target-cause-result differentiation theory
Related Author
No data
Related Institution
Guang’anmen Hospital of China Academy of Chinese Medical Sciences
Beijing University of Chinese Medicine
Gansu University of Chinese Medicine
Dongfang Hospital, Beijing University of Chinese Medicine
Dongzhimen Hospital, Beijing University of Chinese Medicine